CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Mutations in CCAAT/enhancer binding protein α (CEBPA) occur in 5–10% of cases of acute myeloid leukemia. CEBPA-double-mutated cases usually bear biallelic N- and C-terminal mutations and are associated with a favorable clinical outcome. Identification of CEBPA mutants is challenging because of the v...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2017-03-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/8004 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
